Evaluation of angiogenesis in cervical cancer using CD34 as a biomarker and its correlation with pathoanatomical features
<p>Aim: CD34 is an antigen found in hematopoietic progenitor cells and endothelial cells. Anti-CD34 antibody is a highly sensitive marker for neovascularisation and has also been studied as a marker for vascular tumours. However, there are few studies relating it to cervical carcinoma. The aim...
محفوظ في:
المؤلفون الرئيسيون: | Mohsin Aijaz (مؤلف), Kiran Alam (مؤلف), Veena Maheshwari (مؤلف) |
---|---|
التنسيق: | كتاب |
منشور في: |
Annals of Cytology and Pathology - Peertechz Publications,
2021-06-29.
|
الموضوعات: | |
الوصول للمادة أونلاين: | Connect to this object online. |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Diagnostic significance of combined immunohistochemical panel of p63, High Molecular Weight Cytokeratin (34betaE12) and α‑Methyl Acyl Co A Racemase (AMACR) in resolving suspicious foci in prostatic lesions
حسب: Nida Malik, وآخرون
منشور في: (2022) -
Evaluation of Skin Biophysical Parameters and Angiogenesis Using CD34 as a Biomarker in Older Diabetic Women Treated with Radiofrequency
حسب: Sobkowska D, وآخرون
منشور في: (2022) -
EZH2, Endothelin-1, and CD34 as Biomarkers of Aggressive Cervical Squamous Cell Carcinoma: An Immunohistochemical Study
حسب: Anan FATHY, وآخرون
منشور في: (2018) -
Evaluation of Cell Biomarker Gene Expression (CD34) in ALL Patients and Healthy Controls Expression (CD34) in People with Leukemia
حسب: goolshan moradozadeh, وآخرون
منشور في: (2020) -
Correlation between Therapeutic Efficacy of CD34+ Cell Treatment and Directed In Vivo Angiogenesis in Patients with End-Stage Diffuse Coronary Artery Disease
حسب: Tien-Hung Huang, وآخرون
منشور في: (2018)